Shizukaol C
CAS : 142279-41-2
Ref. 3D-SFA27941
5mg | À demander | ||
10mg | À demander | ||
25mg | À demander | ||
50mg | À demander |
Informations sur le produit
- 2-Butenoicacid, 2-methyl-, [1,1a,1b,2,3,4,4a,6,8,8a,9,9a,10,10a,10b,10c,11,11b-octadecahydro-2,9-dihydroxy-7-(hydroxymethyl)-4-(2-methoxy-1-methyl-2-oxoethylidene)-1b,10b-dimethyl-3,6-dioxocyclopropa[4,5]cyclopropa[4',5']cyclopent[1',2':7,8]acephenanthryleno[10a,10-b]furan-9-yl]methylester, [1aR-[1aa,1bb,2b,4ab,4bS*,8aa,9b,9(E),9aa,10aa,10bb,10cb,11ba]]-
- Cyclopropa[4,5]cyclopropa[4',5']cyclopent[1',2':7,8]acephenanthryleno[10a,10-b]furan,2-butenoic acid deriv.
Shizukaol C is a drug-resistant molecule that has been shown to be active against leukemia cells, pancreatic cancer cells, and carcinoma cells. Shizukaol C inhibits the growth of cancer cells by targeting the fatty acid synthesis pathway. The hydroxy group in Shizukaol C interacts with the enzyme ATP citrate lyase, which is involved in fatty acid synthesis. This interaction prevents ATP citrate lyase from functioning properly and blocks the production of fatty acids. Shizukaol C also interacts with other enzymes such as acetyl-CoA carboxylase and ACC-acetyltransferase, which are vital for fatty acid synthesis. These interactions inhibit the production of fatty acids and thereby prevent cell division. Shizukaol C has also been shown to have antifungal properties due to its ability to inhibit fungal growth through inhibition of ergosterol biosynthesis.
Propriétés chimiques
Question d’ordre technique sur : 3D-SFA27941 Shizukaol C
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages